Debra Saunders

Chemical speciation by selective heteronuclear single-quantum coherence spectroscopy: determination of double-bond quantity in unsaturated fatty acid compounds.

Visualization of the protective ability of a free radical trapping compound against rat C6 and F98 gliomas with diffusion tensor fiber tractography.

Diffusion tensor imaging and fiber tractography of C6 rat glioma.

Molecular magnetic resonance imaging approaches used to aid in the understanding of angiogenesis in vivo: implications for tissue engineering.

Sepsis-associated encephalopathy: a magnetic resonance imaging and spectroscopy study.

Molecular magnetic resonance imaging approaches used to aid in the understanding of the tissue regeneration marker Met in vivo: implications for tissue engineering.

In vivo detection of inducible nitric oxide synthase in rodent gliomas.

Molecular MRI assessment of vascular endothelial growth factor receptor-2 in rat C6 gliomas.

Effects of PBN and OKN007 in rodent glioma models assessed by 1H MR spectroscopy.

In vivo characterization of several rodent glioma models by 1H MRS.

Assessment of thermal effects of interstitial laser phototherapy on mammary tumors using proton resonance frequency method.

In vivo imaging of immuno-spin trapped radicals with molecular magnetic resonance imaging in a diabetic mouse model.

ELTD1, a potential new biomarker for gliomas.

Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling.

Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007.

In vivo detection of free radicals using molecular MRI and immuno-spin trapping in a mouse model for amyotrophic lateral sclerosis.

Molecular MRI differentiation of VEGF receptor-2 levels in C6 and RG2 glioma models.

In vivo detection of free radicals in mouse septic encephalopathy using molecular MRI and immuno-spin trapping.

Experimental validation of 5 in-silico predicted glioma biomarkers.

Contrast enhanced magnetic resonance imaging as a diagnostic tool to assess bladder permeability and associated colon cross talk: preclinical studies in a rat model.

OKN-007 decreases tumor necrosis and tumor cell proliferation and increases apoptosis in a preclinical F98 rat glioma model.

In vivo targeted molecular magnetic resonance imaging of free radicals in diabetic cardiomyopathy within mice.

OKN-007 decreases free radical levels in a preclinical F98 rat glioma model.

A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model.

Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts.

OKN-007 decreases VEGFR-2 levels in a preclinical GL261 mouse glioma model.

Assessment of colon and bladder crosstalk in an experimental colitis model using contrast-enhanced magnetic resonance imaging.

Motif mimetic of epsin perturbs tumor growth and metastasis.

Safe Oral Triiodo-L-Thyronine Therapy Protects from Post-Infarct Cardiac Dysfunction and Arrhythmias without Cardiovascular Adverse Effects.

Ameliorative Effects of Antioxidants on the Hippocampal Accumulation of Pathologic Tau in a Rat Model of Blast-Induced Traumatic Brain Injury.

ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models.

Reduced urothelial regeneration in rat bladders augmented with permeable porcine small intestinal submucosa assessed by magnetic resonance imaging.

Gestational hypoxia disrupts the neonatal leptin surge and programs hyperphagia and obesity in male offspring in the Sprague-Dawley rat.

AG488 as a therapy against gliomas.

Therapeutic efficacy of a synthetic epsin mimetic peptide in glioma tumor model: uncovering multiple mechanisms beyond the VEGF-associated tumor angiogenesis.

Preclinical Animal Studies of Intravesical Recombinant Human Proteoglycan 4 as a Novel Potential Therapy for Diseases Resulting From Increased Bladder Permeability.

OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth.

Immunomodulatory response of layered small intestinal submucosa in a rat bladder regeneration model.

Targeting ELTD1, an angiogenesis marker for glioblastoma (GBM), also affects VEGFR2: molecular-targeted MRI assessment.

Using MRI to measure in vivo free radical production and perfusion dynamics in a mouse model of elevated oxidative stress and neurogenic atrophy.

Anti-inflammatory agent, OKN-007, reverses long-term neuroinflammatory responses in a rat encephalopathy model as assessed by multi-parametric MRI: implications for aging-associated neuroinflammation.

Association of decreased levels of lipopolysaccharide-binding protein with OKN-007-induced regression of tumor growth in an F98 rat glioma model.

PEGylated reduced-graphene oxide hybridized with FeO nanoparticles for cancer photothermal-immunotherapy.

Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model.

Molecular changes associated with spinal cord aging.

Assessment of an scFv Antibody Fragment Against ELTD1 in a G55 Glioblastoma Xenograft Model.

Assessing bladder hyper-permeability biomarkers using molecularly-targeted MRI.

Immunologically modified MnFeO nanoparticles to synergize photothermal therapy and immunotherapy for cancer treatment.

Biodegradable pH-responsive amorphous calcium carbonate nanoparticles as immunoadjuvants for multimodal imaging and enhanced photoimmunotherapy.

In vivo and ex vivo assessment of bladder hyper-permeability and using molecular targeted magnetic resonance imaging to detect claudin-2 in a mouse model for interstitial cystitis.

Age-related alterations in the cerebrovasculature affect neurovascular coupling and BOLD fMRI responses: Insights from animal models of aging.

OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma.

ELTD1 as a biomarker for multiple sclerosis: Pre-clinical molecular-targeted studies in a mouse experimental autoimmune encephalomyelitis model.

SuperGAG biopolymers for treatment of excessive bladder permeability.

Rapamycin restores brain vasculature, metabolism, and blood-brain barrier in an inflammaging model.

ELTD1 as a multi-focal target for malignant gliomas: preclinical studies.

Temporary opening of the blood-brain barrier with the nitrone compound OKN-007.

A tale of two multi-focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone-based OKN-007.

MRI as a Tool to Assess Interstitial Cystitis Associated Bladder and Brain Pathologies.

OKN-007 Alters Protein Expression Profiles in High-Grade Gliomas: Mass Spectral Analysis of Blood Sera.

XRN2 Is Required for Cell Motility and Invasion in Glioblastomas.

Novel approaches to combat chemoresistance against glioblastomas.